Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0000950170-23-030904
Filing Date
2023-06-30
Accepted
2023-06-30 07:00:45
Documents
15
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 6-K rnlx-20230629.htm   iXBRL 6-K 36151
2 EX-99.1 rnlx-ex99_1.htm EX-99.1 39416
3 GRAPHIC img102423453_0.jpg GRAPHIC 631
  Complete submission text file 0000950170-23-030904.txt   224614

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT rnlx-20230629.xsd EX-101.SCH 2648
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT rnlx-20230629_def.xml EX-101.DEF 17572
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT rnlx-20230629_pre.xml EX-101.PRE 18366
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT rnlx-20230629_lab.xml EX-101.LAB 22010
9 EXTRACTED XBRL INSTANCE DOCUMENT rnlx-20230629_htm.xml XML 2548
Mailing Address FINSGATE 5-7 CRANWOOD STREET LONDON X0 EC1V 9EE
Business Address FINSGATE 5-7 CRANWOOD STREET LONDON X0 EC1V 9EE 44 29 2071 0570
Renalytix plc (Filer) CIK: 0001811115 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 6-K | Act: 34 | File No.: 001-39387 | Film No.: 231059390
SIC: 8071 Services-Medical Laboratories